发明名称 MUTATIONS OF CRYPTIC SPLICE SITES IN CRE AND CRE FUSED PROTEINS FOR IMPROVEMENT OF EXPRESSION AND INDUCIBILITY
摘要 The invention relates to a DNA sequence, which codes for a mutant of the bacteriophage P1 recombinase, in which a particular cryptic splicing site is disabled by means of a base mutation which alters the Cre protein sequence. The invention further relates to a DNA sequence which codes for a fusion protein from the named Cre mutants and a ligand-binding domain of a receptor protein. The invention furthermore relates to vectors, micro-organisms and transgenic organisms, containing such a DNA sequence and Cre mutants or Cre fusion proteins which are coded by said DNA sequence.
申请公布号 CA2415350(A1) 申请公布日期 2002.01.17
申请号 CA20012415350 申请日期 2001.07.06
申请人 ARTEMIS PHARMACEUTICALS GMBH 发明人 RAJEWSKY, KLAUS;EDENHOFER, FRANK OLIVER STEFAN;WUNDERLICH, THOMAS
分类号 A01H5/00;A01K67/027;C07K14/72;C07K19/00;C12N1/15;C12N1/19;C12N1/21;C12N5/10;C12N9/00;C12N9/10;C12N15/09;C12N15/12;C12N15/52;C12N15/62;C12N15/63;C12N15/67;C12N15/85;(IPC1-7):C12N15/12 主分类号 A01H5/00
代理机构 代理人
主权项
地址